These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34727294)

  • 21. Potential Clinical and Economic Outcomes of Over-the-Counter Hearing Aids in the US.
    Borre ED; Johri M; Dubno JR; Myers ER; Emmett SD; Pavon JM; Francis HW; Ogbuoji O; Sanders Schmidler GD
    JAMA Otolaryngol Head Neck Surg; 2023 Jul; 149(7):607-614. PubMed ID: 37200042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic Evaluation of Treatments for Pediatric Bilateral Severe to Profound Sensorineural Hearing Loss: An Australian Perspective.
    Foteff C; Kennedy S; Milton AH; Deger M; Payk F; Sanderson G
    Otol Neurotol; 2016 Jun; 37(5):462-9. PubMed ID: 26963667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-utility analysis of hearing aid device for older adults in the community: a delayed start study.
    Kaur P; Chong SL; Kannapiran P; Teo WK; Ling CNW; Weichen CW; Ruling G; Yin LS; Leng TY; Pei SY; Kang TT; Han LZ; Peizhen L; Yee LLH; George PP
    BMC Health Serv Res; 2020 Dec; 20(1):1112. PubMed ID: 33261603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models.
    Davis A; Smith P; Ferguson M; Stephens D; Gianopoulos I
    Health Technol Assess; 2007 Oct; 11(42):1-294. PubMed ID: 17927921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cochlear implants in the United Kingdom: awareness and utilization.
    Raine C
    Cochlear Implants Int; 2013 Mar; 14 Suppl 1(Suppl 1):S32-7. PubMed ID: 23453150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hearing-impaired children in the United Kingdom, II: Cochlear implantation and the cost of compulsory education.
    Barton GR; Stacey PC; Fortnum HM; Summerfield AQ
    Ear Hear; 2006 Apr; 27(2):187-207. PubMed ID: 16518145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Economic benefits of the cochlear implant for treating profound sensorineural hearing loss].
    Peñaranda A; Mendieta JC; Perdomo JA; Aparicio ML; Marín LM; García JM; Barón C
    Rev Panam Salud Publica; 2012 Apr; 31(4):325-31. PubMed ID: 22652973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation.
    Norman G; Faria R; Paton F; Llewellyn A; Fox D; Palmer S; Clifton I; Paton J; Woolacott N; McKenna C
    Health Technol Assess; 2013 Nov; 17(52):1-342. PubMed ID: 24267198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-utility analysis of the cochlear implant in children.
    Cheng AK; Rubin HR; Powe NR; Mellon NK; Francis HW; Niparko JK
    JAMA; 2000 Aug; 284(7):850-6. PubMed ID: 10938174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-benefit Analysis of Cochlear Implants: A Societal Perspective.
    Neve OM; Boerman JA; van den Hout WB; Briaire JJ; van Benthem PPG; Frijns JHM
    Ear Hear; 2021; 42(5):1338-1350. PubMed ID: 33675588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Access to aidable residual hearing in adult candidates for cochlear implantation in the UK.
    Fielden CA; Hampton R; Smith S; Kitterick PT
    Cochlear Implants Int; 2016 Apr; 17 Suppl 1():70-3. PubMed ID: 27099116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost Effectiveness of Childhood Cochlear Implantation and Deaf Education in Nicaragua: A Disability Adjusted Life Year Model.
    Saunders JE; Barrs DM; Gong W; Wilson BS; Mojica K; Tucci DL
    Otol Neurotol; 2015 Sep; 36(8):1349-56. PubMed ID: 26171672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cochlear implant in children: rational, indications and cost/efficacy].
    Martini A; Bovo R; Trevisi P; Forli F; Berrettini S
    Minerva Pediatr; 2013 Jun; 65(3):325-39. PubMed ID: 23685383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health State Utility Values Associated with Cochlear Implants in Adults: A Systematic Review and Network Meta-Analysis.
    Dixon PR; Shapiro J; Tomlinson G; Cottrell J; Lui JT; Falk L; Chen JM
    Ear Hear; 2023 Mar-Apr 01; 44(2):244-253. PubMed ID: 36303282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Kearns B; Pandor A; Stevenson M; Hamilton J; Chambers D; Clowes M; Graham J; Kumar MS
    Pharmacoeconomics; 2017 Apr; 35(4):415-424. PubMed ID: 27770303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.
    Hartwell D; Jones J; Baxter L; Shepherd J
    Health Technol Assess; 2011 Apr; 15(17):i-xii, 1-210. PubMed ID: 21473834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2019; 19(7):1-126. PubMed ID: 31911825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial acuity in 2-to-3-year-old children with normal acoustic hearing, unilateral cochlear implants, and bilateral cochlear implants.
    Grieco-Calub TM; Litovsky RY
    Ear Hear; 2012; 33(5):561-72. PubMed ID: 22517185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.
    Dretzke J; Edlin R; Round J; Connock M; Hulme C; Czeczot J; Fry-Smith A; McCabe C; Meads C
    Health Technol Assess; 2011 Feb; 15(6):1-244. PubMed ID: 21291629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.